ALVIMOPAN
Generic: ALVIMOPAN
Hikma Pharmaceuticals USA Inc.Manufacturer
ORALRoute
ALVIMOPANActive Substance
2023-08-31Original Approval
ALVIMOPAN is FDA application ANDA217753, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HOSPITALISATION
19 reports
2
ACUTE KIDNEY INJURY
5 reports
3
ACUTE MYOCARDIAL INFARCTION
4 reports
4
ILEUS
3 reports
5
PRURITUS
3 reports
6
URINARY RETENTION
3 reports
7
ADENOCARCINOMA OF COLON
2 reports
8
CARDIO-RESPIRATORY ARREST
2 reports
9
CHRONIC KIDNEY DISEASE
2 reports
10
DIZZINESS
2 reports